Genome engineering of stem cells for kidney regeneration
Genome engineering of stem cells for kidney regeneration
批准号:
10227657
负责人:
Lauren Elizabeth Woodard
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisAdultAffectAllogenicAnimal ModelAnimalsAristolochic AcidsAutologous Stem Cell TransplantationBiological MarkersBirthCell LineCell TherapyCellsCessation of lifeChronic Kidney FailureClinicClinicalDataDevelopmentDiagnosisDialysis procedureDoxycyclineEmbryoEnd stage renal failureEngraftmentEpithelial CellsEthicsExhibitsFetal DevelopmentFetusFirefly LuciferasesFoundationsGene-ModifiedGenetic DiseasesGenetic EngineeringGenomeGenome engineeringGrowth FactorHistologyHomeHomingHomologous TransplantationHumanImmuneInjuryInjury to KidneyIntensive Care UnitsIschemiaKidneyKidney DiseasesKidney TransplantationLegal patentLifeLuciferasesMeasuresMesenchymeMethodsMitochondriaModelingMorbidity - disease rateMusMutationNatural regenerationNephrologyNephronsOptical TomographyOutcomePatientsPhenotypeProductionPropertyProximal Kidney TubulesPublishingRegenerative engineeringRenal Replacement TherapyRenal functionReperfusion InjuryReperfusion TherapyRhabdomyolysisSeveritiesSiteSourceTechniquesTestingTherapeuticTimeToxinTransfectionUnited StatesUrineVeteransadult stem cellbasecancer therapycell typecostdonor stem cellengineered stem cellsfetalfunctional improvementgene therapyimmunogenicimproved functioningin vivoinduced pluripotent stem cellinjuredinjury and repairinterestkidney cellkidney repairmilitary veteranmortalitymouse modelnephron progenitornovel therapeuticsoptical imagingparacrinepre-clinicalregeneration functionregenerativerenal damagerepairedstem cell biomarkersstem cell therapystem cellstomographytranscription factortransplantation therapy
中文摘要
我们建议开发一种再生基因和细胞疗法来治疗急性肾损伤和/或慢性肾损伤。
肾脏疾病。这些研究是基于从尿液中分离成人干细胞的最新进展。
尿液来源的干细胞有几个显著的特性:它们很容易获得,可以繁殖很多次
通道,是多功能的,也是受伤部位的家园。我们建议对尿液来源的干细胞进行基因组修饰
并在三种小鼠肾损伤模型(缺血再灌注、横纹肌溶解和
马兜铃酸)。细胞将被转座子修饰以表达荧光素酶。这将允许在现场进行跟踪
通过光学成像与先进的层析成像新技术一起研究动物。肾损伤的生物标志物
将被测量和比较。组织学和标记分析将确定干细胞是否对
每种情况下的小鼠表型。目标1旨在比较接受尿源性干细胞治疗的小鼠的结果
细胞与不处理的对比。在目标2中,尿液来源的干细胞将被重新编程为诱导的肾单位祖细胞
细胞,并与过去的诱导肾单位祖细胞的方法进行比较。这些细胞是独一无二的
因为它们与帽间充质中发现的细胞相似,并能够分化为
肾单位。这些目标将决定基于尿液的异基因或自体干细胞移植疗法-
来源干细胞可能具有逆转或延缓急性肾损伤小鼠模型肾损害的能力
受伤或慢性肾脏疾病。
英文摘要
We propose to develop a regenerative gene and cell therapy treatment for acute kidney injury and/or chronic
kidney disease. These studies are based on recent advances in isolation of adult stem cells from the urine.
Urine-derived stem cells have several remarkable properties: they are easy to obtain, propagate for many
passages, are multipotent, and home to sites of injury. We propose to genome modify urine-derived stem cells
and track their homing in three mouse models of kidney injury (ischemia reperfusion, rhabdomyolysis, and
aristolochic acid). Cells will be modified with transposons to express luciferase. This will permit tracking in live
animals by optical imaging together with new techniques for advanced tomography. Biomarkers for kidney injury
will be measured and compared. Histology and marker analysis will determine if stem cells have an effect on the
mouse phenotype for each condition. Aim 1 seeks to compare outcomes for mice receiving urine-derived stem
cells vs no treatment. In Aim 2, urine-derived stem cells will be reprogrammed into induced nephron progenitor
cells and compared to past methods of deriving induced nephron progenitor cells. These cells are unique
because they are similar to cells found in the cap mesenchyme and are capable of differentiating into all parts of
the nephron. These aims will determine if allogeneic or autologous stem cell transplant therapies based on urine-
derived stem cells may have the ability to reverse or delay kidney damage in mouse models of acute kidney
injury or chronic kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome engineering of stem cells for kidney regeneration
-
批准号:10454857
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Lauren Elizabeth Woodard
-
依托单位:
Genome engineering of stem cells for kidney regeneration
-
批准号:10012479
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Lauren Elizabeth Woodard
-
依托单位:
Genome engineering of stem cells for kidney regeneration
-
批准号:10618860
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Lauren Elizabeth Woodard
-
依托单位:
In Situ Reprogramming of Induced Nephron Progenitor Cells for Kidney Regeneration
-
批准号:10064117
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Lauren Elizabeth Woodard
-
依托单位:
海外基金